vivaldop t1_jdh16bn wrote
Reply to comment by Bird_skull667 in Phase 1 study: New medicine extends terminally-ill cancer patients' lives. Seventy percent of the patients who tested the medicine were stable after six weeks. Twelve continued the medication and were stable for 18 weeks. One woman took the medication for 17 months, and was stable for over two years by Wagamaga
Thank for the info
Viewing a single comment thread. View all comments